Hier finden Sie wissenschaftliche Publikationen aus den Fraunhofer-Instituten.

Ameliorated or acquired cytostatic/cytotoxic properties of nucleosides by lipophilization

: Knies, C.; Bonaterra, G.; Hammerbacher, K.; Cordes, A.; Kinscherf, R.; Rosemeyer, H.


Chemistry & biodiversity : CB 12 (2015), No.12, pp.1902-1944
ISSN: 1612-1872
ISSN: 1612-1880
Bundesministerium für Wirtschaft und Technologie BMWi
KF 2369401 SB9
Journal Article
Fraunhofer IME ()

A series of nucleolipids, containing one of the beta-D-ribonucleosides 5-fluorouridine, 6-azauridine, uridine, or 5-methyluridine were lipophilized, either at the O-2', 3'-position and/or at N(3) of the nucleobase with a large variety of hydrophobic residues. The resulting nucleolipids as well as the parent nucleosides and the lipid precursors were investigated in vitro with respect to their antitumor activity towards i) ten human tumor cell lines from the NCI 60 panel and ii) partly against three further tumor cell lines, namely a) human astrocytoma/oligodendro glioma GOs-3, b) rat malignantneuroectodermal BT4Ca, and c) differentiated human THP-1 macrophages. Inspection of the dose response curves allows two main conclusions concerning lipid determinants lending the corresponding nucleoside an ameliorated or an acquired antitumor activity: i) introduction of either a symmetrical O-2',3'-nonadecylidene ketal group or introduction of an O-2',3'-ethyl levulinate moiety plus an N(3)-farnesyl group leads often to nucleolipids with significant cytostatic/cytotoxic properties; ii) for the two canonical and non-toxic nucleosides uridine and 5-methyluridine, the condensation with also non-toxic lipids gives nucleolipids with a pronounced antitumor activity.